INTRODUCTION
Creating new, original medicines is an incredibly complicated and expensive process. This axiom is well known to scholars who are actively engaged in this problem. In addition to pharmacological and toxicological documentation, the development and testing of methods for quality control of active pharmaceutical ingredients (APIs) is mandatory for implementation [1] [2] [3] .
Derivatives of 1,2,4-triazole are actively researched by scientific teams around the world on the ability to manifest a wide range of biological effects [4] [5] [6] . Thus, in the scientific literature there is available data on their use as antimicrobial, anti-inflammatory, analgesic, antiepileptic, antiviral, antihypertensive, antimalarial, sedative, antihistamines, anti-TB drugs, etc. [4, 5, 7, 8] . Interesting enough in pharmacological way, there are 2-((5-R-4-R1-4H-1,2,4-triazole-3-yl)thio) acetic acid salts, for which a wide range of pharmacological activity has been researched [7, 9, 10] . Of these salts, The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl) thio)acetate, which along with low toxicity, exhibits antioxidant and hepatoprotective properties [11] . Therefore, the development of a method for determination the API in the substance is one of the important steps towards the creation of a new medicinal product [12] [13] [14] .
The purpose of this work is to develop a method for determining the API in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate substance, using the method of high-performance liquid chromatography with diode-matrix detection (HPLC-DAD).
MATERIALS AND METHODS
As an object of research, potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (structure I, Fig.1 ) was used [15] . The study of the physical and chemical properties of the resulting compounds was carried out according to the methods presented in the State Pharmacopoeia of Ukraine (SPU) [16, 17] .
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Materials
Reagents: acetonitrile qualification "HPLC Super Gradient" (Avantor Performance Materials Poland S.A., Poland), formic acid (100%) (AppliChem GmbH, Germany), ultra-high pure water (18 MΩ at 25°C) was obtained by using the system for water Direct Q 3UV Millipore (Molsheim, France).
The substance of potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (structure I) (API) was used. The compound was synthesized at Department of Toxicological and Inorganic Chemistry, Zaporizhzhya State Medical University. The chromatography system suitability test. The number of theoretical plates N at the API peak should be ≥ 4,000 (length of column 50 mm).
Preparation of the mobile phase A. 1.00 mL of the formic acid was diluted to 1000.0 mL with a high purity water and was mixed.
Preparation of the mobile phase B. 1.00 mL of the formic acid was diluted to 1000.0 mL with acetonitrile and was mixed.
Preparation of a reference solution. 100 mg (precise weight) of the standard potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate was dissolved in 50 mL of high purity water, then it was diluted to 100.0 mL with water and was mixed thoroughly.
Preparation of the solution for chromatographic system suitability test. 100 mg of the standard API sample was dissolved in 50 mL of a high purity water then was diluted to 100.0 mL with the water and was mixed thoroughly.
Preparation of the research solution. 100 mg (precise weight) of the research sample of the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate substance was dissolved in 50 mL of high purity water, then it was diluted to 100.0 mL with the water and was mixed thoroughly.
The solution was then chromatographed for assessing the suitability of the chromatographic system n times, calculating relative standard deviation (RSD) for peak API area; the chromatography was stopped when the obtained RSD value was less than the RSD max value or equal, that is given in the State Pharmacopeia of Ukraine (SPU) and SPU (Supplement 1) [16, 17] and calculated according to the European Pharmacopeia method 2.2.46 (SYSTEM SUITABILITY) [18] for the upper limit given in the definition of the individual monograph, minus 100 per cent API content B = 2% (Table 1) . Alternately, the reference solution was chromatographed and the research solution was determined by the number of times (n). The retention time of the API peak should be about 4.4 minutes.
The API content in the substance potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate X, %, was determined by the formula:
where: 
RESULTS AND DISCUSSION
Reasoning of chromatographic quantitative determination conditions:
The compound which was studied is very hydrophilic with small retention (in the void volume) on reverse phase sorbent (C18). That is why the silica sorbent RX-SIL in HILIC (hydrophilic chromatography) mode was used. As the eluent, a mixture of water and acetonitrile (20:80) was used in the presence of 0.1% methanolic acid.
The substance which was synthesized firstly was studied by chromatography with DAD and MS detection.
Using a diode array detector at a wavelength of 254 nm, we detected an impurity that was released at 2.7 minutes (Fig. 2) .
S st × m x × (100 -w)
This unknown structure was not detected on the mass spectrometric detector in the positive ionization mode, at a voltage value of the 10 V fragmentor, scanning from 100 to 500 m/z, the gas velocity of the nebulizer of 10 L/min, gas pressure of the nebulizer of 60 psig, temperature of gasdehydrator (nitrogen) of 300°С.
Therefore, in order to achieve the main objective of the work, the identification and removal of an impurity in potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (API) are needed.
It was proposed that the impurity might not fall within the standard scan range, so it was expanded to m/z 50-500. This decision did not lead to a positive result, which suggested that it is possible to detect the impurity in the negative mode (Mode name). As a result, the voltage on the fragmentor was increased to 50 V, to increase the sensitivity of detection (with increasing voltage, the ion current increases and, accordingly, more ions enter the skimmer) [19] .
It should be noted that these actions did not help in detecting the impurity either at 50 V, or at 100, 150, 200, 250 V. At the same time, the intensity of the peak of the main component first grew, and then decreased, due to fragmentation of the molecule. These results allowed us to return to the positive ionization regime and increase the voltage on the fragmentator to 100 V, and then to 150 V. The impurity was, hence, detected and the intensity of the peak of this impurity increased. A characteristic peak of the ion with m/z 216.1 (Fig. 3) was then observed on the mass spectrum, which could correspond to the quasimolecular ion (M + H + ) of the initial product of the synthesis of 4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-thiol (structure III, Fig. 1 ). Subsequently, an intermediate component of the synthesis of potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (API) -2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetic acid (structure II, Fig. 1 ) was seen. As a result, the same impurity was observed, with the same m/z and retention time.
Further, for the final identification of the impurity, an analysis was made of the starting component 4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-thiol (structure III, Fig. 1 ). The resulting mass spectrum and retention time (Fig. 4) coincided with those for the impurity, which confirmed that this impurity is 4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-thiol ( structure III).
The results obtained suggest that in the research sample, potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (API) yield of 2.713 min (Fig. 2) corresponds to the starting product of the synthesis, namely 4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-thiol (structure III, Fig. 1 ). Therefore, potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (API) was obtained by double recrystallization in which no impurities of the starting products were detected, which made it possible to use this substance to prepare a reference solution (Fig. 5) .
Determination of the linear range of the method
Linearity was determined by introducing into the chromatographic system 0.8; 0.85; 0.9; 0.95; 1; 1.05; 1.1; The largest coefficient of linear regression was observed at 254 nm, that is why we chose this wavelength (Fig. 6 ).
Quantitative determination of API potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate in the substance
The solution of standard sample was chromatographed 5 times. The results are presented in Tables 2, 3 . The obtained RSD value was in the requirements of the SPU to the RSD% max at all n values, starting with n = 2. Therefore, we chromatographed 2 times in turn of the reference solution and the research solution [16, 17] . Chromatogram of research solution of potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (API) is shown in Fig. 7 . 
CONCLUSIONS
Due to the development of a method for determination of the API in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate, the substance was researched using the HPLC-DAD method. From the study of the API sample, the admixture of the original component of 4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-thiol was identified. The results of determining the contents of the API in real samples indicate that the method can be proposed to control the quality of the substance potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl) thio)acetate.
